Bright Peak Therapeutics

Switzerland
Allschwil, Basel-Landschaft, Switzerland, 4123

Company profile

Bright Peak Therapeutics company profile

Bright Peak is a biotech company that develops a portfolio of immunotherapies for the treatment of cancer and autoimmune diseases. The company's immunotherapies allow tissue and cell-specific targeting of the cytokine payload with the added potential for significantly enhanced efficacy.

Business identity

Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2017-12-13

Headquarters

Postal code
4123
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
3
Total equity funding
$232M
Last funding
Series C / $90M / 2024-06-11
Last equity funding
Series C / $90M
Investors
11
Lead investors
3
Founders
2
Articles
42

Founders and investors

Founders

Jeffrey BodeVijaya Pattabiraman

Lead investors

Johnson & Johnson InnovationRA Capital ManagementVersant Ventures

Investors

BlackRockFidelityNorthleaf Capital PartnersRA Capital ManagementVenrock